We are live on ! Find out more
CC

Cannell Capital Portfolio holdings

AUM $149M Turnover 39.58%
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+11.13%
1 Year Est. Return
+39.81%
3 Year Est. Return
+127.36%
5 Year Est. Return
+127.84%
10 Year Est. Return
+2,416.91%
AUM
$350M
AUM Growth
+$34.9M
Cap. Flow
+$12.1M
Cap. Flow %
3.45%
Top 10 Hldgs %
52.18%
Holding
84
New
17
Increased
25
Reduced
14
Closed
8
Avg Time Held
1.2 years
Top 10 Avg Time Held
0.9 years
Top 20 Avg Time Held
1.3 years

Sector Composition

Rank Sector Weight
1 Industrials 20.57%
2 Healthcare 19.63%
3 Financials 18.35%
4 Energy 16.61%
5 Consumer Discretionary 12.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RVP icon
76
Retractable Technologies
RVP
$17.2M
– –
-133,410
Closed -$148K –
IMBI
77
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
– –
-128,800
Closed -$1.65M –
TMX
78
DELISTED
Terminix Global Holdings, Inc.
TMX
– –
-6,418
Closed -$179K –
VAL icon
79
DELISTED
Valspar
VAL
– –
-4,748
Closed -$527K –
WWAV
80
DELISTED
The WhiteWave Foods Company
WWAV
– –
-9,178
Closed -$515K –
HK
81
DELISTED
Halcon Resources Corporation
HK
– –
-260,998
Closed -$2.01M –

Similar funds

Cannell Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Cannell Capital held 84 positions worth $350M, up 11% from $315M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Cannell Capital deployed $12.1M of net new capital in Q2 2017, opening 17 new positions and adding to 25 existing holdings. Its largest new stake was Kindred Biosciences, Inc.: 379,874 shares worth $3.27M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was BioTelemetry, Inc., an estimated $6.83M trimmed.

  • Cannell Capital's largest Q2 2017 buy was Kindred Biosciences, Inc.: 379,874 shares worth $3.27M.
  • Cannell Capital added most to eHealth in Q2 2017, an estimated $14.6M increase.
  • Cannell Capital's biggest Q2 2017 reduction was BioTelemetry, Inc., cutting an estimated $6.83M.
  • Cannell Capital fully exited Happen Inc in Q2 2017, selling an estimated $8.51M.
  • Cannell Capital's ten largest holdings make up 52% of its $350M portfolio in Q2 2017.
  • Cannell Capital opened 17 new positions and closed 8 in Q2 2017.
  • Cannell Capital's portfolio value rose 11% quarter-over-quarter to $350M.

Based on Cannell Capital's 13F filing for Q2 2017, filed 14 Aug 2017.